跳至主要内容
临床试验/ACTRN12620000524998
ACTRN12620000524998尚未招募未知

ReCOVER (Remote COVID-19 Evaluation and Response): a prospective non-randomised controlled trial to evaluate the effect of a novel smartphone application-centric model of care for the remote monitoring of COVID-19 patients in the community, on avoidable hospital presentations..

South Eastern Sydney Local Health District0 个研究点目标入组 2,000 人开始时间: 2020年4月28日最近更新:

试验速览

阶段
未知
状态
尚未招募
入组人数
2,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Age greater or equal to 18 years
  • 2. Able to provide informed consent
  • 3. Proven diagnosis of COVID-19 based on positive virology testing
  • 4. Patients who are being managed at home OR those who are being discharged from hospital for ongoing home-based care in isolation.
  • 5. Access to a smartphone or device that is compatible with the TCC-COVID app
  • oAny iPhone or iPad running iOS 9 or above (essentially any iPhone 5 or above)
  • oAny Android phone that is operating Android 7.0 or above
  • 6. Speaks adequate English

排除标准

  • 1. Patient meets clinical criteria for hospital-based care.
  • 2. Inability to use the TCC-COVID app and pulse oximeter due to reasons including but not limited to:
  • oCognitive impairment
  • oImpaired dexterity
  • oVisual impairment
  • oLanguage barrier
  • 3. Patient residing outside the SESLHD catchment area during their period of isolation

研究者

相似试验